Skip to main content

American Epilepsy Society (AES), 2025

Filter
Close
Content type:
Patient and Caregiver Preferences for Acute Seizure Medications: A Quantitative Survey
Cédric Laloyaux, Tommi Tervonen, Vicente Villanueva, et al.
Patient and Caregiver Perceptions of Acute Seizure Medications and the Rapid and Early Seizure Termination (REST) Approach: Qualitative Interviews
Kerrie-Anne Ho, Tommi Tervonen, Jesus Eric Pina-Garza, et al.
Bridging the Divide: Enhancing Communication Between People Living With an Epilepsy and Their Healthcare Providers to Improve Care
Danya Kaye, Cheryl Hudson, Cédric Laloyaux, et al.
Describing the Population of Patients With Prolonged Seizures: US Subgroup Results From a Global Real-World Point-in-Time Study
Eugen Trinka, Matthew C Walker, Reetta Kälviäinen, et al.
AAV Mediated Overexpression of STXBP1 Variants in a Mouse Model of STXBP1 Haploinsufficiency
Christian Wolff, Jérôme Clasadonte, Yana van den Herrewegen, et al.
Reactive Mouse Primary Astrocytes as a Model to Explore Glial Gene Expression Profiles Identified in Human Temporal Lobe Epilepsy
Marek Rajman, Anouk Verboven, Josephine Lenfant, et al.
AAV Gene Therapy in Juvenile Mice of STXBP1 Haploinsufficiency
Natalia Rodriguez, Jérôme Clasadonte, Yana van den Herrewegen, et al.
Healthcare Resource Utilization and Costs With the Introduction of Intranasal Midazolam in Acute Seizure Management: A Wisconsin-Based Claims Analysis
George L Morris, Derek Ems, Anna Kuba, et al.
Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Seizures: Results of a Phase II/III, Open-Label, Randomized, Active Comparator Trial
Brian Moseley, Jody M Cleveland, Walter Krauwinkel, et al.
Long-Term Use of Oral Lacosamide in Young Children With Epilepsy Who Received Lacosamide in Previous Trials: Data From a Multicenter, Open-Label, Follow-Up Trial
Carrie McClung, Lien Heinzen, Anne-Liv Schulz, et al.
Association of Fenfluramine Treatment and Everyday Executive Functioning in Adults With Lennox-Gastaut Syndrome
Delphine Breuillard, Kelly G. Knupp, Adam Strzelczyk, et al.
Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Nicola Specchio, Eric Marsh, Orrin Devinsky, et al.
Final Results From a Long-Term Open-Label Extension Study (Up to 4 Years): Tolerability of Fenfluramine and Global Functioning of Pediatric and Adult Patients With Dravet or Lennox-Gastaut Syndromes
Antonio Gil-Nagel, Kelly G Knupp, Boudewijn Gunning, et al.
Mortality Rates and Risk Factors Among Patients With Lennox-Gastaut Syndrome or Dravet Syndrome
Elizabeth J. Donner, Tracy Dixon-Salazar, Jaya Khushalani, et al.
Impacts of Disruptive Seizures, Sleep, and Behaviors on Activities of Daily Living and Communication in Developmental and Epileptic Encephalopathies: Interim Results of a Caregiver Survey
Laurie D. Bailey, David R. Bearden, Brad Bryan, et al.
Streamlining the Process of Caregiving for a Loved One with Dravet or Lennox-Gastaut Syndrome
Nikita Meer, Colin Lake, Tanja S. Kellermann
Long-Term Safety, Tolerability, and Efficacy of Brivaracetam in Patients With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Madalina Leanca, Sophia Bakhtadze, Christoph Reichel, et al.
Digital Application Usage in Epilepsy: Insight From Real-World Setting Studies BRIVA-Reg and BRITOBA
Vasilios Kimiskidis, Magdalena Bosak, Milan Brázdil, et al.
Tolerability and Efficacy of Adjunctive Brivaracetam in Japanese and Chinese Patients With Focal Seizures: Phase 3, Open-Label Extension Trial
Ayataka Fujimoto, Bing Qin, Juliane Koch, et al.
Fenfluramine Persistence in Patients With Lennox-Gastaut Syndrome: A Retrospective Analysis Using US Claims Data
Wesley T. Kerr, Jaya Khushalani, Heidi L. Henninger, et al.
Healthcare Resource Utilization and Antiseizure Medication Claims in Patients With Lennox-Gastaut Syndrome Receiving Fenfluramine in the United States
Adam Strzelczyk, Jaya Khushalani, Heidi L. Henninger, et al.